Articles by George Koroneos, Online Content & News Editor - Pharmaceutical Executive

ADVERTISEMENT

Articles by George Koroneos, Online Content & News Editor

Search Ad Warnings Leave Pharma in Online Void

Apr 15, 2009

After last week’s flurry of FDA warning letters directed at companies marketing through search ads, industry is left wondering what can be done be done to target patients online?

J&J Eliminates 900 Sales Positions

Apr 15, 2009

In an effort to realign its sales division to reflect the current pharma environment—smaller, faster, better—Johnson & Johnson is trimming its sales force.

Boehringer Ingelheim Launches New Site for TIA Sufferers

Apr 15, 2009

Rather than ignore its aging mini-stroke medication Aggrenox, BI has shifted marketing to education by launching an unbranded site dedicated to informing sufferers about transient ischemic attacks, better known as TIA.

Pharma Companies Hit With Warnings for Search Marketing

Apr 8, 2009

FDA is cracking down on content in search engine advertisements. The argument is that there is a serious deficiency of risk information in the tiny link ads that appear on search ads. With pharma already wary of marketing online, will FDA’s tactic hurt future Web campaigns?

Pfizer Begins Wyeth Integration with New Research Structure

Apr 8, 2009

Just two months after the purchase of Wyeth, Pfizer breaks its research division into two—one for large molecules and vaccines, and another for small molecules—with Wyeth and Pfizer execs at the helms.

FDA Demands Pharma Firms Pull Unapproved Drugs

Apr 1, 2009

The Feds are on the warpath, cracking down on pharmaceutical companies that manufacture and market unapproved prescription narcotics.

Prescription Abandonment Numbers on the Rise

Apr 1, 2009

Compliance woes and stingy insurance providers are walloping the pharmaceutical industry. But now another nuisance is rearing its ugly head, as a high number of patients are ignoring their doctor's orders and dropping their prescriptions on purpose.

Shire Joins with GSK to Promote ADHD Drug

Apr 1, 2009

Now that Vyvanse, Shire's innovative ADD drug, has been approved for adults, the company needs help to quickly roll out a complex message to neurologists. Its solution: a partnership that takes advantage of GSK's CNS muscle.

Lilly's Zyprexa/Prozac Combo Approved for Depression

Mar 25, 2009

After repeated requests for additional study information, the wait has paid off: Lilly was approved to sell its bipolar drug Symbyax for treatment-resistant depression.

ADVERTISEMENT

Click here